Kimberly A Forde

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
    K A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    J Viral Hepat 19:271-7. 2012
  2. pmc Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 Ravdin, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 7:1121-6. 2009
  3. pmc No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease
    Mark T Osterman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 9:875-80. 2011
  4. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
  5. pmc Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection
    Zina Meriden
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 8:289-96, 296.e1-8. 2010
  6. doi request reprint Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
  7. doi request reprint Immunosuppressant medications and mortality in inflammatory bowel disease
    James D Lewis
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Gastroenterol 103:1428-35; quiz 1436. 2008
  8. pmc Do statins reduce hepatitis C RNA titers during routine clinical use?
    Kimberly A Forde
    Research Section, Philadelphia Veterans Administration Medical Center, Research A402A, 3900 Woodland Avenue, Philadelphia, PA 19104, United States
    World J Gastroenterol 15:5020-7. 2009
  9. pmc Factors that predict short-term intensive care unit mortality in patients with cirrhosis
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 11:1194-1200.e2. 2013
  10. doi request reprint Hepatitis C virus infection and immunomodulatory therapies
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Liver Dis 13:391-401. 2009

Collaborators

Detail Information

Publications10

  1. pmc Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
    K A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    J Viral Hepat 19:271-7. 2012
    ..16; 95% CI, 0.77-1.74). In conclusion, HCV infection was not associated with an increased risk of incident MI...
  2. pmc Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 Ravdin, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 7:1121-6. 2009
    ..In patients with chronic liver disease, race plays a role in the rate of survival after transplantation. It is not known how race and ethnicity influence the presentation, etiology, and outcomes in patients with acute liver failure (ALF)...
  3. pmc No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease
    Mark T Osterman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 9:875-80. 2011
    ..We aimed to determine the risk of first-time acute MI in patients with ulcerative colitis (UC) or Crohn's disease (CD) compared with patients from general practice...
  4. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
    ..This study assessed whether the recorded incidence of cancer among patients in The Health Improvement Network (THIN) database is comparable to that expected in the UK based on national cancer registry data...
  5. pmc Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection
    Zina Meriden
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 8:289-96, 296.e1-8. 2010
    ..Recurrent hepatitis C with ensuing fibrosis is the leading cause of liver allograft loss. We investigated whether histologic features in early posttransplant liver biopsies could predict the rate of fibrosis progression in this population...
  6. doi request reprint Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
    ....
  7. doi request reprint Immunosuppressant medications and mortality in inflammatory bowel disease
    James D Lewis
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Gastroenterol 103:1428-35; quiz 1436. 2008
    ..This study examined whether treatment of Crohn's disease (CD) and ulcerative colitis (UC) with immunosuppressant medications was associated with an increased risk of death in the era prior to antitumor necrosis factor (TNF) therapies...
  8. pmc Do statins reduce hepatitis C RNA titers during routine clinical use?
    Kimberly A Forde
    Research Section, Philadelphia Veterans Administration Medical Center, Research A402A, 3900 Woodland Avenue, Philadelphia, PA 19104, United States
    World J Gastroenterol 15:5020-7. 2009
    ..To compare hepatitis C virus (HCV) titers in patients with chronic hepatitis C with and without exposure to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)...
  9. pmc Factors that predict short-term intensive care unit mortality in patients with cirrhosis
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 11:1194-1200.e2. 2013
    ..We aimed to identify factors that predict early (7 d) mortality among patients with cirrhosis admitted to the intensive care unit (ICU) and to develop a risk-stratification model...
  10. doi request reprint Hepatitis C virus infection and immunomodulatory therapies
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Liver Dis 13:391-401. 2009
    ..In this article, the authors discuss immunomodulatory therapies and clinical trials in the treatment of HCV infection...